Annual accounts
Medium accounts
30/09/2027Filing deadline
Made up to 31/12/2025Due 30/09/2027
- Next accounts made up to
- 31/12/2026
- Last accounts made up to
- 31/12/2025
GENESIS PHARMACEUTICALS LIMITED
ActiveRegistry details
Reference data exactly as held at Companies House.
Copy registry details
- Registered office
- Scottish Provident House 3rd Floor, 76 - 80 College Road, Harrow, Middlesex HA1 1BQ
- Classification (SIC)
- Wholesale of pharmaceutical goods (46.46 - SIC 2007)
- Accounts type
- Medium
Company activity
The 4 most recent documents filed at Companies House.
Pre-Score for UK companies is coming soon
- 20/03/2026View PDF (4 pages)
Confirmation statement made on 2026-03-05 with updates
- 28/10/2025View PDF (2 pages)
Change of details for Mr David Louis Charles Solomon as a person with significant control on 2024-12-17
- 30/09/2025View PDF (33 pages)
Accounts for a medium company made up to 2024-12-31
- 21/11/2024View PDF (3 pages)
Statement of capital following an allotment of shares on 2024-11-08
Coming soon
What Pre-Score will tell you
- Whether the filed accounts are strengthening or weakening year on year.
- Whether this company files on time, and how often its record changes.
- How its officers and controlling parties connect to other UK companies.
Accounts and confirmation statement
The two filings Companies House requires every year, and where each one stands against its deadline today.
On schedule
Confirmation statement
Confirms the registry record is up to date
19/03/2027Filing deadline
Last statement 05/03/2026Due 19/03/2027
- Next statement date
- 05/03/2027
- Last statement dated
- 05/03/2026
Financial performance
The latest figures GENESIS PHARMACEUTICALS LIMITED filed. Okredo holds filed accounts data for 2021–2024; the year-by-year record is on the financials page.
Net Assets
£2.71M2024
10.14%vs 20232023: £2.46M
Total Assets
£15.26M2024
-15.81%vs 20232023: £18.13M
Cash in Bank
£195.49K2024
-48.81%vs 20232023: £381.90K
Total Liabilities
£11.13M2024
-21.44%vs 20232023: £14.17M
Employees
122024
+1vs 20232023: 11
Of the 4 measures with an earlier filing to compare against, 1 rose and 3 fell. Total liabilities moved furthest, down 21.44% on 2023. See the full financial analysis for GENESIS PHARMACEUTICALS LIMITED.
The full financial record
Four ways through GENESIS PHARMACEUTICALS LIMITED's filed accounts — the year-by-year numbers, the compound rates and the ratios behind them.
Net Assets · +10.8% a year (CAGR)Three-year trend, 2022–2024Every measure end to end across 2022, 2023 and 2024, with the compound rate behind each one.See what moved5 chartsCharts by indicator5 filed indicators plotted year by year, 2021–2024.Plot the figuresNothing estimatedRatios from the filed figures5 ratios computed from this company's own reported amounts, each shown against the year it was derived from.Check the ratios5 × 4 yearsEvery figure by yearAll 5 measures Okredo tracks across 4 reported years, exactly as filed.Open the table
Employees
Headcount as reported to Companies House for 2021–2024.
| Year | Employees | Change |
|---|---|---|
| 2024 | 12 | +1 |
| 2023 | 11 | 0 |
| 2022 | 11 | 0 |
| 2021 | 11 | – |
Reported employee count increased from 11 in 2021 to 12 in 2024. See how headcount moved alongside the reported financials.
Credit report
It is a professional assessment of the company 's performance, revealing company's potential and risks, showing it's past experiences and revealing future prospects.
- Company potential
- Risk indicators
- Past performance
- Future prospects
Officers
11Directors, secretaries and other appointed officers, with the period each has served.
| Person | Role | Period | Connected companies |
|---|---|---|---|
| Nominee Director | 29/09/1999–29/09/1999 | 5391 | |
| Nominee Secretary | 29/09/1999–29/09/1999 | 6736 | |
| Director | 29/09/1999–31/07/2005 | 13 | |
| Director | 05/04/2008–21/05/2011 | 9 | |
| Director | 21/07/2008–08/08/2023 | 13 | |
| Director | 29/09/1999–Present | 22 | |
| Director | 29/09/1999–31/07/2005 | 9 | |
| Secretary | 29/09/1999–Present | 3 | |
| Director | 01/10/2010–Present | 3 | |
| Director | 29/09/1999–Present | 15 | |
| Director | 08/08/2023–Present | 9 |
Persons with significant control
3Individuals or entities with significant control over the company, as declared to Companies House.
| Person | Period | Connected companies |
|---|---|---|
| 29/12/2022–Present | 2 | |
| 30/12/2022–Present | 2 | |
| 05/04/2016–29/12/2022 | 0 |
Filing history and recent activity
Every document on the Companies House record, newest first.
- Filings on record
- 21
- Since 21/10/2022
- Last 12 months
- 2
- -2 vs the year before
- Most recent filing
- 20/03/2026
- 6 months ago
What changed in the last year
- Confirmation statementLatest 20/03/2026
- Officer changesLatest 28/10/2025
Filing timeline
- 20/03/2026View PDF (4 pages)
Confirmation statement made on 2026-03-05 with updates
- 28/10/2025View PDF (2 pages)
Change of details for Mr David Louis Charles Solomon as a person with significant control on 2024-12-17
- 30/09/2025View PDF (33 pages)
Accounts for a medium company made up to 2024-12-31
- 21/11/2024View PDF (3 pages)
Statement of capital following an allotment of shares on 2024-11-08
- 21/11/2024View PDF (3 pages)
Statement of capital following an allotment of shares on 2024-11-08
- 21/11/2024View PDF (3 pages)
Statement of capital following an allotment of shares on 2024-11-08
- 26/09/2024View PDF (32 pages)
Full accounts made up to 2023-12-31
- 20/06/2024View PDF (3 pages)
Confirmation statement made on 2024-06-04 with no updates
- 30/10/2023View PDF (32 pages)
Full accounts made up to 2022-12-31
- 22/08/2023View PDF (1 pages)
Termination of appointment of Bharat Prataprai Mehta as a director on 2023-08-08
- 22/08/2023View PDF (2 pages)
Appointment of Mr Sidharth Mehta as a director on 2023-08-08
- 17/08/2023View PDF (1 pages)
Satisfaction of charge 1 in full
Showing 12 of 21 filings
See when the next accounts and confirmation statement are due
Similar companies
1 UK company is similar to GENESIS PHARMACEUTICALS LIMITED, sharing the same company status (Active), the same industry sector and activity group (Wholesale of pharmaceutical goods) and a comparable number of employees. It is shown below to help you compare competitors and industry peers.
SUNCROP PRODUCE LIMITED
ActiveChilterns, Commonside Road, Harlow, Essex CM18 7EZ
- Activity
- Wholesale of fruit and vegetables
- Company no.
- 03255798
- Incorporated
- 27/09/1996
- Employees
- 14
About GENESIS PHARMACEUTICALS LIMITED
A short description of the company, written from its Companies House record.
GENESIS PHARMACEUTICALS LIMITED is a private limited company registered in the United Kingdom, based in Scottish Provident House 3rd Floor, 76 - 80 College Road, Harrow, Middlesex HA1 1BQ. Companies House classifies its business as Wholesale of pharmaceutical goods. It has been on the register for 27 years.
The register currently records it as active. Its 2024 accounts report net assets of £2.71M and 12 employees.
GENESIS PHARMACEUTICALS LIMITED: frequently asked questions
Answered from this company's own registry record and filed figures.
Companies House records GENESIS PHARMACEUTICALS LIMITED under one registered business activity: Wholesale of pharmaceutical goods (46.46 - SIC 2007).
GENESIS PHARMACEUTICALS LIMITED is recorded as active on the Companies House register, and has been on it since 29/09/1999.
The most recent accounts Okredo holds cover 2024 and report net assets of £2.71M, total assets of £15.26M, cash in bank of £195.49K and total liabilities of £11.13M.
The most recent document on the record is dated 20/03/2026: Confirmation statement made on 2026-03-05 with updates, 6 months ago.
On the current registry record, accounts are due by 30/09/2027 and the next confirmation statement is due by 19/03/2027.
Companies House lists 11 officers (5 currently in post) and 3 people with significant control (2 current).